Revenue$482.4 million for FY 2019$118.9 million for Q4 2019Cash from operating activities$96.1 million for FY 2019$15.3 million for Q4 2019Adjusted […]
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) — Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused […]